Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Chartmaster: Big move in vaccine names
06:13pm, Friday, 21'st Oct 2022
Carter Worth of Worth Charting on what's next in the health care sector. With CNBC's Frank Holland and the Fast Money traders, Tim Seymour, Steve Grasso, Guy Adami and Julie Biel.
AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth
02:00pm, Friday, 21'st Oct 2022 Zacks Investment Research
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Corcept (CORT) Thrives on Korlym, Overdependence a Concern
03:26pm, Thursday, 20'th Oct 2022 Zacks Investment Research
Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since approval. However, sole dependence on Korlym for revenues remains a headwind.
Earnings Preview: Merck (MRK) Q3 Earnings Expected to Decline
02:02pm, Thursday, 20'th Oct 2022 Zacks Investment Research
Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Merck (MRK) Dips More Than Broader Markets: What You Should Know
09:45pm, Wednesday, 19'th Oct 2022 Zacks Investment Research
Merck (MRK) closed the most recent trading day at $93.26, moving -1.43% from the previous trading session.
Beat the Dow Jones With This Unstoppable Dividend Stock
01:30pm, Wednesday, 19'th Oct 2022 The Motley Fool
This pharmaceutical stock combines strong financials with an above-average dividend.
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
01:00pm, Wednesday, 19'th Oct 2022 Zacks Investment Research
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Beat the Dow Jones With This Unstoppable Dividend Stock
09:30am, Wednesday, 19'th Oct 2022
This pharmaceutical stock combines strong financials with an above-average dividend.
Merck Nears Breakout Point After October Surprise Good News
08:01am, Wednesday, 19'th Oct 2022
Dow component Merck is within 2% of an all-time high after rallying 7.30% in the past month. It got a boost from news about two new treatments.
Will This News Send Moderna's Stock Soaring?
01:25pm, Tuesday, 18'th Oct 2022 The Motley Fool
The company has been working on diversifying its pipeline.
Is Invesco Dow Jones Industrial Average Dividend ETF (DJD) a Strong ETF Right Now?
10:20am, Tuesday, 18'th Oct 2022 Zacks Investment Research
Smart Beta ETF report for DJD
What the Smartest Investors Know About Moderna Stock
09:52am, Tuesday, 18'th Oct 2022 The Motley Fool
It's important to understand Moderna's near-term challenges and its long-term opportunities.
Moderna CEO: Merck deal ‘could be a game changer' for cancer treatment
04:07pm, Monday, 17'th Oct 2022
Moderna CEO Stéphane Bancel spoke with Anjalee Khemlani at Yahoo Finance's All Markets Summit about the company's deal with Merck to develop a cancer vaccine.
Dow Jones Leader Merck Breaks Out; 3 Other Top Stocks To Watch
12:35pm, Monday, 17'th Oct 2022
Dow Jones leader Merck is breaking out past a buy point while other top stocks to watch include AutoZone, Cardinal and Molina Healthcare. The post Dow Jones Leader Merck Breaks Out; 3 Other Top Stocks
Why Shares of Keros Therapeutics Rose 10.2% This Week
11:38pm, Friday, 14'th Oct 2022 The Motley Fool
A sympathetic reaction to a competitor's drug helped push the clinical-stage pharmaceutical company's shares higher.
